Peter A Kiener
CIK 1328146 · Chief Science Officer · last filed 2026-01-06
Peter A Kiener is a Chief Science Officer who has filed 34 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for CUE, was dated Jan 6, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $237.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$237.5K
4
34
-$1.22M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CUE | Director | 9,682 | $24.53 | $237.5K | -$392.3K | 11 | 2026-01-06 |
| LAVA Therapeutics NV (LVTX) Delisted | Director | — | $1.74 | — | $0 | 2 | 2025-11-17 |
| PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Director | — | $13.60 | — | $0 | 7 | 2023-06-23 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Chief Science Officer | 0 | — | — | -$825.0K | 14 | 2018-02-13 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | CUE | Grant (A) | — | $0 | EDGAR |
| 2025-11-17 | LAVA Therapeutics NV (LVTX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-02-18 | LAVA Therapeutics NV (LVTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-03 | CUE | Grant (A) | — | $0 | EDGAR |
| 2024-01-04 | CUE | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-27 | CUE | Mixed | +357 | -$2.9K | EDGAR |
| 2023-01-05 | CUE | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | CUE | Grant (A) | — | $0 | EDGAR |